Imatinib mesylate induces apoptosis in human cholangiocarcinoma cells (Q40487604)

21 September 2017

title

Imatinib mesylate induces apoptosis in human cholangiocarcinoma cells (English)

1 reference

21 September 2017

0 references

0 references

1 reference

3

1 reference

21 September 2017

6

Gregory J Gores

1 reference

21 September 2017

Mihnea V Chiorean

1

1 reference

21 September 2017

Maria Eugenia Guicciardi

series ordinal

2

1 reference

21 September 2017

Steven F Bronk

series ordinal

4

1 reference

21 September 2017

Scott H Kaufmanns

series ordinal

5

1 reference

21 September 2017

publication date

1 December 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

24

1 reference

21 September 2017

issue

6

1 reference

21 September 2017

page(s)

687-695

1 reference

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Cholangiocarcinoma: Current concepts and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Oncogenic kinase signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced ce

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Untangling the ErbB signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Structural basis for the autoinhibition of c-Abl tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

ARG tyrosine kinase activity is inhibited by STI571.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Central role of Fas-associated death domain protein in apoptosis induction by the mitogen-activated protein kinase kinase inhibitor CI-1040 (PD184352) in acute lymphocytic leukemia cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Role of E2F and ERK1/2 in STI571-mediated smooth muscle cell growth arrest and cyclin A transcriptional repression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Imatinib mesylate (STI571; Glivec)???a new approach in the treatment of biliary tract cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Expression of Kit and platelet-derived growth factor receptors α and β in cholangiocarcinoma, and case report of therapy with imatinib mesylate (STI571)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Bench to bedside: the development of rapamycin and its application to stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

Stent development and local drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

An audit of metal stent palliation for malignant biliary obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0984.X

10.1111/J.1478-3231.2004.0984.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference